Metagenomi Statistics

Total Valuation

Metagenomi has a market cap or net worth of $151.57 million. The enterprise value is -$76.95 million.

Market Cap	151.57M
Enterprise Value	-76.95M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025, before market open.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Metagenomi has 37.42 million shares outstanding. The number of shares has increased by 621.16% in one year.

Current Share Class	37.42M
Shares Outstanding	37.42M
Shares Change (YoY)	+621.16%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	10.93%
Owned by Institutions (%)	29.64%
Float	23.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.81
Forward PS	5.46
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.18, with a Debt / Equity ratio of 0.18.

Current Ratio	6.18
Quick Ratio	6.06
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.34% and return on invested capital (ROIC) is -19.01%.

Return on Equity (ROE)	-30.34%
Return on Assets (ROA)	-14.85%
Return on Capital (ROIC)	-19.01%
Revenue Per Employee	$233,390
Profits Per Employee	-$313,364
Employee Count	236
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	-1.58M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.31
200-Day Moving Average	4.77
Relative Strength Index (RSI)	67.38
Average Volume (20 Days)	4,784,528

Short Selling Information

The latest short interest is 271,482, so 0.73% of the outstanding shares have been sold short.

Short Interest	271,482
Short Previous Month	443,564
Short % of Shares Out	0.73%
Short % of Float	1.16%
Short Ratio (days to cover)	0.60

Income Statement

In the last 12 months, Metagenomi had revenue of $55.08 million and -$73.95 million in losses. Loss per share was -$3.01.

Revenue	55.08M
Gross Profit	-55.69M
Operating Income	-88.47M
Pretax Income	n/a
Net Income	-73.95M
EBITDA	-83.33M
EBIT	-88.47M
Loss Per Share	-$3.01

Full Income Statement

Balance Sheet

The company has $274.59 million in cash and $46.07 million in debt, giving a net cash position of $228.51 million or $6.11 per share.

Cash & Cash Equivalents	274.59M
Total Debt	46.07M
Net Cash	228.51M
Net Cash Per Share	$6.11
Equity (Book Value)	255.77M
Book Value Per Share	6.83
Working Capital	236.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$103.39 million and capital expenditures -$4.52 million, giving a free cash flow of -$107.91 million.

Operating Cash Flow	-103.39M
Capital Expenditures	-4.52M
Free Cash Flow	-107.91M
FCF Per Share	-$2.88

Full Cash Flow Statement

Margins

Gross margin is -101.11%, with operating and profit margins of -160.63% and -134.27%.

Gross Margin	-101.11%
Operating Margin	-160.63%
Pretax Margin	-137.13%
Profit Margin	-134.27%
EBITDA Margin	-151.28%
EBIT Margin	-160.63%
FCF Margin	n/a

Dividends & Yields

Metagenomi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-621.16%
Shareholder Yield	-621.16%
Earnings Yield	-48.79%
FCF Yield	-71.19%

Analyst Forecast

The average price target for Metagenomi is $16.67, which is 311.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.67
Price Target Difference	311.61%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Metagenomi has an Altman Z-Score of 0.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.78
Piotroski F-Score	2